| The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN … A Karakatsanis, PM Christiansen, L Fischer, C Hedin, L Pistioli, M Sund, ... Breast cancer research and treatment 157, 281-294, 2016 | 146 | 2016 |
| The use of pre-or postoperative antibiotics in surgery for appendicitis: a systematic review K Daskalakis, C Juhlin, L Påhlman Scandinavian Journal of Surgery 103 (1), 14-20, 2014 | 146 | 2014 |
| Association of a prophylactic surgical approach to stage IV small intestinal neuroendocrine tumors with survival K Daskalakis, A Karakatsanis, O Hessman, HC Stuart, S Welin, ET Janson, ... JAMA oncology 4 (2), 183-189, 2018 | 96 | 2018 |
| Clinical signs of fibrosis in small intestinal neuroendocrine tumours K Daskalakis, A Karakatsanis, P Stålberg, O Norlén, P Hellman Journal of British Surgery 104 (1), 69-75, 2017 | 77 | 2017 |
| Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer A Karakatsanis, K Daskalakis, P Stålberg, H Olofsson, Y Andersson, ... Journal of British Surgery 104 (12), 1675-1685, 2017 | 67 | 2017 |
| Activity and safety of standard and prolonged capecitabine/temozolomide administration in patients with advanced neuroendocrine neoplasms E Chatzellis, A Angelousi, K Daskalakis, M Tsoli, KI Alexandraki, ... Neuroendocrinology 109 (4), 333-345, 2019 | 58 | 2019 |
| Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis E Alevroudis, ME Spei, SN Chatziioannou, M Tsoli, G Wallin, G Kaltsas, ... Cancers 13 (8), 1813, 2021 | 44 | 2021 |
| Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study C Nesti, K Bräutigam, M Benavent, L Bernal, H Boharoon, J Botling, ... The lancet oncology 24 (2), 187-194, 2023 | 41 | 2023 |
| Gastric neuroendocrine neoplasms type 1: a systematic review and meta-analysis AV Tsolakis, A Ragkousi, M Vujasinovic, G Kaltsas, K Daskalakis World Journal of Gastroenterology 25 (35), 5376, 2019 | 36 | 2019 |
| Indication for liver transplantation in young patients with small intestinal NETs is rare? O Norlén, K Daskalakis, K Öberg, G Åkerström, P Stålberg, P Hellman World journal of surgery 38, 742-747, 2014 | 32 | 2014 |
| The risk of lymph node metastases and their impact on survival in patients with appendiceal neuroendocrine neoplasms: a systematic review and meta-analysis of adult and … K Daskalakis, K Alexandraki, E Kassi, M Tsoli, A Angelousi, A Ragkousi, ... Endocrine 67, 20-34, 2020 | 23 | 2020 |
| DcR3, TFF3, and midkine are novel serum biomarkers in small intestinal neuroendocrine tumors K Edfeldt, K Daskalakis, C Bäcklin, O Norlén, E Tiensuu Janson, G Westin, ... Neuroendocrinology 105 (2), 170-181, 2017 | 23 | 2017 |
| Pathogenesis and clinical management of mesenteric fibrosis in small intestinal neuroendocine neoplasms: a systematic review A Koumarianou, KI Alexandraki, G Wallin, G Kaltsas, K Daskalakis Journal of Clinical Medicine 9 (6), 1777, 2020 | 22 | 2020 |
| Currently available treatment options for neuroendocrine liver metastases N Machairas, K Daskalakis, E Felekouras, KI Alexandraki, G Kaltsas, ... Annals of gastroenterology 34 (2), 130, 2021 | 20 | 2021 |
| Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms K Daskalakis, M Tsoli, A Karapanagioti, M Chrysochoou, D Thomas, ... Clinical endocrinology 91 (4), 534-543, 2019 | 18 | 2019 |
| Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms K Daskalakis, E Chatzelis, M Tsoli, N Papadopoulou-Marketou, ... Endocrine 64, 384-392, 2019 | 17 | 2019 |
| The role of serum 5-HIAA as a predictor of progression and an alternative to 24-h urine 5-HIAA in well-differentiated neuroendocrine neoplasms M Wedin, S Mehta, J Angerås-Kraftling, G Wallin, K Daskalakis Biology 10 (2), 76, 2021 | 16 | 2021 |
| Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms K Daskalakis, M Tsoli, A Angelousi, E Kassi, KI Alexandraki, D Kolomodi, ... Endocrine Connections 8 (6), 641-653, 2019 | 15 | 2019 |
| Changing biological behaviour of NETs during the evolution of the disease: progress on progression KI Alexandraki, A Spyroglou, S Kykalos, K Daskalakis, G Kyriakopoulos, ... Endocrine-Related Cancer 28 (5), R121-R140, 2021 | 13 | 2021 |
| Endocrinological toxicity secondary to treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) KI Alexandraki, K Daskalakis, M Tsoli, AB Grossman, GA Kaltsas Trends in Endocrinology & Metabolism 31 (3), 239-255, 2020 | 13 | 2020 |
